N/A Completed N=90 Randomized Double-blind Treatment

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

Ejaculatory Dysfunction · BPH

Source: ClinicalTrials.gov NCT05914519 ↗

Enrolled (actual)

Serious AEs

1.1%

Results posted

Jan 2026

Primary outcomePrimary: Preservation of Ejaculation — 34; 8 Participants

Summary

The purpose of this study is to assess the outcomes and efficacy of ejaculatory preserving TURP in terms of voiding, erectile function, and ejaculation.

Outcome Measures

Outcome	Result	p-value
PRIMARY Preservation of Ejaculation	34; 8	—
SECONDARY Maximum Flow Rate (Qmax)	18.78; 19.71	—

Eligibility Criteria

Inclusion Criteria

Adult patient > 45 years old.
Drug refractory urinary retention.
Prostate volume range: 20-60 mL.
IPSS > 19 after the medical therapy failure.
Qmax < 10 mL/s.
PSA < 4 ng/mL.
Active and healthy sexual life.

Exclusion Criteria

History of prostate or urethral surgery.
Neurogenic bladder.
UTI.
Urethral stricture disease.
prostate cancer.
Bleeding diathesis.
Capsular or bladder perforation during surgery.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05914519). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.